The American Academy of Neurology’s (AAN) 65th Annual Meeting took place in San Diego, California in March. This large medical conference presents the latest findings in research and treatments for neurological conditions, including multiple sclerosis (MS). To follow are some important highlights.
Read News ArticleCategory: Latest News
PML Reported in Psoriasis Patients Taking Fumaric Acid Medications in Europe
Two cases of progressive multifocal leukoencephalopathy (PML) in individuals taking either fumaric acid or a compound of fumaric acid esters were reported in The New England Journal of Medicine (N Engl J Med 2013;368;17:1657-1660) on April 25, 2013. PML is a potentially fatal brain infection with the JC virus (JCV), in people with weakened immune systems. Both of these reports were from Europe in individuals receiving long-term treatment for psoriasis (a chronic skin problem that causes skin cells to grow too quickly, resulting in thick, white, silvery, or red patches of skin [WebMD]).
Read News ArticleTecfidera Approved for the Long-Term Treatment of MS
The United States Food and Drug Administration (FDA) announced on March 27, 2013 that it has approved Tecfidera (dimethyl fumarate or DMF, formerly known as BG-12) as a first-line therapy for the long-term treatment of relapsing forms of multiple sclerosis (MS). Tecfidera’s parent company, Biogen Idec, submitted a New Drug Application (NDA) to the FDA for the approval of this drug in February 2012. (Read the FDA’s press release on the approval of Tecfidera.)
Read News ArticleMarch is MS Awareness Month
The Multiple Sclerosis Association of America (MSAA) recognizes March as MS Awareness Month. Throughout March, MSAA encourages individuals to expand their knowledge, understanding, and support of individuals whose lives are affected by multiple sclerosis (MS).
Read News ArticleThe Multiple Sclerosis Association of America Launches New Website
The Multiple Sclerosis Association of America (MSAA) is pleased to introduce its new website, mymsaa.org.
Read News ArticleMultiple Sclerosis Association of America Teams Up With SwimOutlet.com To Promote Swim For MS
The Multiple Sclerosis Association of America (MSAA) is pleased to announce its new partnership with SwimOutlet.com to help promote the charity’s national fundraiser, Swim for MS. Serving as the distribution sponsor for Swim for MS, SwimOutlet.com will feature promotional information and ongoing updates on swim events through newsletter articles, targeted email campaigns, and posts on social media including Facebook and Twitter.
Read News ArticleFlu and Flu Vaccine Information
Recent news reports and statistical information indicate that this year the incidence rate for seasonal influenza (flu) is already high and is widely impacting communities across the nation. The good news is that the flu immunization prepared for the 2012-2013 flu season appears to be very well matched to those flu strains occurring across the country; therefore, preventative measures such as obtaining a flu vaccine may be helpful in preventing the contraction of the flu.
Read News ArticleMSAA’s Mobile Phone App Launches in the Android Marketplace
My MS Manager™, the first-of-its-kind mobile phone application developed to help individuals better manage their MS, is now available on the Android platform. Since its launch in the Apple App Store in June of 2011, My MS Manager has been downloaded more than 9,000 times, with users entering data about their MS on various Apple mobile products.
Read News ArticleEmergency and Assistive Services in Response to Hurricane Sandy
The impact of Hurricane Sandy to the residents of the mid-Atlantic, Northeastern, and Midwestern United States has been devastating. MSAA’s staff is deeply saddened by the tragic loss of life as well as the destruction of personal possessions, homes, and businesses, caused by this storm.
Read News ArticleVaccination Safety
Recent studies continue to aff …
Read News Article